| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/12/2004 | WO2004039326A3 Propofol with cysteine |
| 08/12/2004 | WO2004029073A3 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 08/12/2004 | WO2004026231A3 Formulation for lipophilic agents |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2004020623A3 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 08/12/2004 | WO2004019867A3 Breath freshening and oral cleansing product using cardamom oil |
| 08/12/2004 | WO2004009664A3 Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from |
| 08/12/2004 | WO2003103592A3 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 08/12/2004 | WO2003057133A9 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 08/12/2004 | WO2003032913A3 Methods and compositions for targeting proteins across the blood brain barrier |
| 08/12/2004 | WO2003015606A3 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 08/12/2004 | US20040158288 Method and apparatus for treating tumors using low strength electric fields |
| 08/12/2004 | US20040158041 Chemically modified G-CSF |
| 08/12/2004 | US20040158038 Pullan-trehalose fusion which enhances functionality of seasonings, spices, colorings, flavorings, emulsifiers and plasticizers |
| 08/12/2004 | US20040157991 Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol) |
| 08/12/2004 | US20040157953 Materials for filling cavities in the body |
| 08/12/2004 | US20040157936 Anhydrous topical skin preparations |
| 08/12/2004 | US20040157925 Stable pharmaceutical composition of pravastatin |
| 08/12/2004 | US20040157887 Antisecretory agents; gastrointestinal agents |
| 08/12/2004 | US20040157884 Accurate, long duration, controlled release of opioids at small dosage levels; implants; minimizing tissue trauma |
| 08/12/2004 | US20040157876 Solid dosage forms; melt granulation |
| 08/12/2004 | US20040157840 Rifalazil compositions and therapeutic regimens |
| 08/12/2004 | US20040157825 Quinolone carboxylic acid compositions and related methods of treatment |
| 08/12/2004 | US20040157816 Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents |
| 08/12/2004 | US20040157815 fluticasone propionate is completely dissolved in a hydrofluoroalkane (HFA) propellant for use in metered dose inhalers |
| 08/12/2004 | US20040157810 Corticosteroid conjugates and uses thereof |
| 08/12/2004 | US20040157797 poorly water soluble active agent with solubilizing agent crystalline methylated beta -cyclodextrin; active agent is carbamazepine, fenofibrate, oxcarbazepine, or glipizide |
| 08/12/2004 | US20040157796 Concentrated liquid valdecoxib composition |
| 08/12/2004 | US20040157769 Stabilized pharmaceutical composition in lyophilized form |
| 08/12/2004 | US20040157767 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 08/12/2004 | US20040157755 Novel detergent compositions with enhanced depositing, conditioning and softness capabilities |
| 08/12/2004 | US20040157734 Supersuperabsorbent polymers, preparation thereof and use thereof |
| 08/12/2004 | US20040157330 Compositions and methods for targeted biological delivery of molecular carriers |
| 08/12/2004 | US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157207 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
| 08/12/2004 | US20040157073 Lubricious coatings for substrates |
| 08/12/2004 | US20040156993 a coating liquid for preperation of a hard coating layer for food or medicine containing any one of sugar/sugar alcohols selected from maltitol, xylitol, erythritol, mannitol, lactitol, trehalose, sucrose, and oxidized starch |
| 08/12/2004 | US20040156930 A dissolving patch containing antibiotics (penicillin, amoxicillin) or other medicants (amlexanox and licorice (glycyrrhiza) extract) to treat canker sores of the mouth through sustained release of the healing agents |
| 08/12/2004 | US20040156919 device for concentrating drugs on a lesion by injecting magnetized drugs into blood vessels and then applying (either from outside or inside the body) a magnetic field around the lesion; one time administration of anticancer agents |
| 08/12/2004 | US20040156914 Slow release protein polymers |
| 08/12/2004 | US20040156913 poly(alpha-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, or a polycyanoacrylate, formed using detergents; biologically active macromolecule adsorbed on surface |
| 08/12/2004 | US20040156909 especially amphiphilic cationic or anionic vinyl ether polymers (e.g., copolymerized with maleic anhydride) electrostatically or covalently attached to the polynucleotide |
| 08/12/2004 | US20040156908 Prevention of indwelling device related infection: composition and methods |
| 08/12/2004 | US20040156907 Pharmaceutical compositions using semi-solid delivery vehicle |
| 08/12/2004 | US20040156906 Thermosensitive and biodegradable microgel and a method for the preparation thereof |
| 08/12/2004 | US20040156904 matrix of PEG-g-chitosan and water insoluble polylactic acid, poly-lactide glycolide, polycaprolactones, EVA, or polyanhydridie used as a delivery vehicle for pharmaceuticals and biomedical materials. |
| 08/12/2004 | US20040156901 Pharmaceutical composition of topiramate |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156899 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 08/12/2004 | US20040156891 gradient loading procedure, at a pH that prevents precipitation of the drug from the loading solution; preparing giant multivesicular liposomes with high drug-to-lipid ratios; provide long term analgesia. |
| 08/12/2004 | US20040156887 Stabilized dispersion of phytosterol in oil |
| 08/12/2004 | US20040156885 Water soluble film for oral administration with instant wettability |
| 08/12/2004 | US20040156874 Urea- a topical anti-inflammatory |
| 08/12/2004 | US20040156871 hydrophilic/hydrophobic solubilizer such as polyoxyethanyl-sitosterol sebacate, polyoxyethanyl-cholesteryl sebacate or polyoxyethanyl- alpha-tocopheryl sebacate with a polyene macrolide antibiotic or a polyunsaturated fatty acid oil |
| 08/12/2004 | US20040156870 administering urea to the affected area of human skin either before, after or with a topical anti-inflammatory drug. |
| 08/12/2004 | US20040156859 GP-41 peptides, BBB peptides, anticancer agents, antihistamines, bronchodilators, hypotensive agents, antiangina agents, opioids, analgesics, antidepressants, and hypothyroid agents reactive with amino, hydroxyl or thiol groups |
| 08/12/2004 | US20040156840 A preferred IgM is autoantigen IgM, in particular anti-ds-DNA and anti-phospholipid IgM; may be mixed with an antiinflammatory agent, an immunosuppressive agent and/or a cytostatic agent |
| 08/12/2004 | US20040156836 combination of coenzyme Q and a surfactant can prevent ascites even when administering in a small dose and within a short period of time |
| 08/12/2004 | US20040156835 Protein preparation |
| 08/12/2004 | US20040156824 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 08/12/2004 | US20040156823 inner structures of the syringe are coated with an inductor and the syringe is filled with a body fluid, incubated and a therapeutically-effective protein, e.g., interleukin 1 receptor antagonist, interleukin-4, interleukin-10 and tumour necrosis factor receptor Type I or Type II is formed |
| 08/12/2004 | US20040156816 Lipid-drug complexes in reversed liquid and liquid crystalline phases |
| 08/12/2004 | US20040156791 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 08/12/2004 | US20040156790 Delivery of drug esters through an inhalation route |
| 08/12/2004 | US20040156789 Delivery of antihistamines through an inhalation route |
| 08/12/2004 | US20040156788 Delivery of erectile dysfunction drugs through an inhalation route |
| 08/12/2004 | US20040156787 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic theraphy and in vivo diagnostic |
| 08/12/2004 | US20040156783 Complexes of cyanine, indocyanine, phthalocyanine, rhodamine, oxazine, thiazine, phenoselenazines, fluoresceins, porphyrin, squaraine, corrins, croconium, azo, methine and/or indolenium dye linked with receptor binding molecules; tumors |
| 08/12/2004 | US20040156781 Polymeric materials for site specific delivery to the body |
| 08/12/2004 | DE10331253A1 Composition for treating fish infections comprises polyethylene glycol and a water-insoluble active ingredient |
| 08/12/2004 | CA2573363A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | CA2573241A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | CA2573228A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | CA2573194A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | CA2514560A1 Composition for preventive treatment of cold sores |
| 08/12/2004 | CA2514536A1 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes |
| 08/12/2004 | CA2513893A1 Multiparticulate compositions of milnacipran for oral administration |
| 08/12/2004 | CA2513769A1 Method for evaluating the efficacy of certain cancer treatments |
| 08/12/2004 | CA2512988A1 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same |
| 08/11/2004 | EP1445325A1 Processes for producing isomaltose and isomaltitol and use thereof |
| 08/11/2004 | EP1444991A1 Novel targeted compositions for diagnostic and therapeutic use |
| 08/11/2004 | EP1444987A2 Oral vaccine against diarrhea |
| 08/11/2004 | EP1444335A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444264A2 Methods and materials for targeting and affecting selected cells |
| 08/11/2004 | EP1444263A2 Method for improving stability of a bone-connecting implant |
| 08/11/2004 | EP1443969A2 Non-inclusion cyclodextrin complexes |
| 08/11/2004 | EP1443968A1 Edible film |
| 08/11/2004 | EP1443964A1 Photodynamic therapy for the treatment of hair loss |
| 08/11/2004 | EP1443963A2 Antibody targeting compounds |
| 08/11/2004 | EP1443960A2 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 08/11/2004 | EP1443950A2 A plant extract active as an immunostimulating agent |
| 08/11/2004 | EP1443938A1 Dosage unit comprising a prostaglandin analog for treating constipation |
| 08/11/2004 | EP1443932A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 08/11/2004 | EP1443929A2 Treatment of cns disorders using cns target modulators |
| 08/11/2004 | EP1443921A1 PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO 5.2.1.0 sp 2.6 /sp -DEC-9-YL XANTHOGENATE AND MEDICAMENTS THEREFROM |
| 08/11/2004 | EP1443917A1 Tamsulosin tablets |
| 08/11/2004 | EP1443912A2 Compositions having a combination of immediate release and controlled release characteristics |
| 08/11/2004 | EP1443911A1 Process for preparing quick dissolving, high loading ribavirin compositions |